Of these genes, TAGLN2 (Beyer et al., 2018; Han et al., 2017), FN1 (Yu et al., 2020; Gu, Gu & Shou, 2014; Guo, Heller & Thorslund, 2016; Liao et al., 2018), TTYH3 (Weinberg et al., 2020), GRN, (Ness, Riemenschneider & Baches., 2009; Trigos et al., 2019) have been reported in GBM. This evidence concerns the gene GRN and glioblastoma.